Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes
- Sponsor
- Providence VA Medical Center
- Enrollment
- 118
- Locations
- 1
- Primary Endpoint
- Percentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm Hg
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The purpose of this research is to study whether a multidisciplinary education in Diabetes and intervention for cardiac risk reduction in a group setting to modify patient behavior and adjust medications can achieve diabetes guideline goals for glycemia, blood pressure and lipid control.
Investigators
Wen-Chih Wu
Staff Cardiologist
Providence VA Medical Center
Eligibility Criteria
Inclusion Criteria
- •All diabetic veterans with a Hb-A1c between 7.0- 9.0 % within the last 6 months will be eligible for the study
Exclusion Criteria
- •Patients without an Hb-A1c checked within the last 6 months.
- •Patients who are unable to attend the group sessions, either because of lack of transportation, psychiatric instability (suicidal, psychotic), or organic brain injury that preclude them from diabetes self-care.
Outcomes
Primary Outcomes
Percentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm Hg
Time Frame: 4 months
The major outcome was the percentage of participants who attain the target goals for A1C, blood pressure,and ldl cholesterol lipids set by the American Diabetes Association guidelines, defined as A1C \<7%, SBP \<130 mm Hg, diastolic blood pressure (DBP) \<80 mm Hg, and LDL cholesterol \<100 mg/dL (2.6 mmol/L).